Medical Device Pricing Research & Pricing Strategy

It examines how different stakeholders perceive value, how trade-offs are made between cost and outcomes, and how procurement, reimbursement, and budget constraints shape willingness to pay.

Get in touch

At IDR Medical, our work is grounded first and foremost in rigorous qualitative and quantitative MedTech market research. We help manufacturers move from intuition, legacy assumptions, and competitor benchmarking to evidence-based pricing strategies aligned with real-world buying behaviour.

This research-led approach ensures pricing reflects how healthcare organisations actually make decisions — not how prices are set internally.

Why pricing strategy matters in MedTech

Pricing is one of the most consequential commercial decisions manufacturers make, yet it is often one of the least evidence-based.

Medical device pricing fails when it ignores how healthcare organisations actually buy. Common challenges include:

medical-device-unmet-needs-clinical-insight-analysis-matters-image

Treating price as a one-off launch decision rather than a strategic capability

Over-reliance on competitor benchmarking without understanding perceived value

Limited insight into how clinicians, procurement, finance, and leadership trade off cost, outcomes, and workflow impact

Underestimating how procurement frameworks, reimbursement, and value-based purchasing shape willingness to pay

Leading MedTech organisations address these challenges by embedding market research into pricing strategy, ensuring pricing reflects real decision logic across the buying unit.

How we research pricing and willingness to pay

Our approach to pricing combines deep qualitative insight with advanced quantitative methods, designed specifically for the complexity of medical device markets.

Where appropriate, we apply best-practice quantitative techniques widely used in medical device pricing research, including:

Conjoint analysis (CBC / ACBC) to quantify trade-offs between features, service, performance, and price
Gabor-Granger to measure willingness-to-pay and price sensitivity
Van Westendorp Price Sensitivity Meter to define acceptable price ranges and value thresholds

These methods move pricing decisions beyond stated opinions to defensible, evidence-based recommendations.

Talk to us

Stakeholder research across the buying unit

In-depth interviews with clinicians, nurses, procurement teams, Value Analysis Committees, finance, biomedical engineering, and senior leadership to understand decision criteria and perceived value.

Value driver and trade-off analysis

Identification of which product attributes truly drive choice, and how stakeholders trade off clinical outcomes, usability, service, and workflow impact against price.

Pricing and willingness-to-pay research

Structured exploration of price sensitivity, acceptable price ranges, and perceived fairness across segments and use cases.

Segmentation and portfolio logic

Assessment of how pricing should vary across customer segments, care settings, geographies, and product portfolios.

Scenario-based pricing simulations

Testing of alternative pricing structures to understand the impact on adoption, revenue, and competitive positioning.

From pricing insight to confident commercial decisions

Our medical device pricing research translates insight into clear, decision-ready guidance. Our role is not only to analyse price sensitivity, but to help teams apply pricing evidence to real commercial and strategic decisions.

Typical outcomes include

Defensible price points aligned with customer value and market realities
Clear insight into segmentation, trade-offs, and portfolio optimisation
Evidence to support internal pricing approval and governance processes
Stronger positioning in negotiations, tenders, and contracting discussions
Greater confidence in launch pricing and long-term revenue planning

medical-device-unmet-needs-clinical-insight-medtech-lifecycle-image

Where pricing research fits in the MedTech lifecycle

Pricing research and pricing strategy play a critical role across multiple stages of the product lifecycle. It often follows value proposition and buying process research and supports launch execution, market access, and commercial strategy, ensuring pricing is aligned with real-world decision logic.

Pre-launch business case and investment planning
Launch pricing and positioning
Tender, procurement, and contracting strategy
Portfolio optimisation and indication expansion
Post-launch price optimisation and defence

Lets talk

A practical evidence base for pricing and growth

Our work delivers a structured, reusable evidence base that commercial, pricing, and leadership teams can rely on over time. Outputs are designed to directly inform pricing frameworks, negotiation strategies, and portfolio decisions, always grounded in how value and price are actually evaluated by buyers.

medical-device-unmet-needs-clinical-insight-practical-research-toolikit-image

Case Studies

Explore our case studies focusing on Medical Device Pricing Research & Pricing Strategy to discover how we have supported our clients to succeed in the past.

Frequently Asked Questions

Competitor benchmarks show what others charge, not what customers are willing to pay or how they trade off value. Pricing research reveals the underlying decision logic behind price acceptance or resistance.

We conduct research with clinicians, procurement professionals, finance teams, Value Analysis Committees, biomedical engineers, and healthcare decision-makers involved in evaluation, approval, and purchasing.

Pricing research focuses on external value perception and decision behaviour. Financial models focus on internal economics. Both are needed, but they answer different questions.

Ideally before launch, major pricing changes, or portfolio decisions - but it is also valuable when negotiating tenders, entering new markets, or facing pricing pressure.

Switzerland (Head Quarters)

UK

USA

Medical Device Pricing Research & Pricing Strategy

Why pricing strategy matters in MedTech

Want to know more?

How we research pricing and willingness to pay